Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation

NCT07226557 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

5000

Enrollment

NIH

Sponsor class

Conditions

Carbapenem Resistant Bacterial Infection
Acinetobacter Baumannii Infection
Antimicrobial Drug Resistance

Sponsor

National Institutes of Health Clinical Center (CC)